News

Tesetaxel is a novel, orally absorbed taxane that has been evaluated in a completed or ongoing Phase 2a/Phase 2b clinical trials. The Phase 2b study enrolled 41 gastric

The company’s first collection is Vitality, a line of accessories for medication and pill management. The nine products in Sabi’s Vitality line, include: Carafe, Chop Crushfolio, Grande Carafe,

WEP has developed two proprietary biopolymer technologies, PolyPEG and GlycoPol, and the company plans to license deals for these technologies this year. WEP’s PolyPEG is a low viscosity

The initial studies with rabies VLP vaccine demonstrated that two doses of one or four micrograms induced protective levels of neutralizing antibodies in a mouse model. The company

The new kits will allow pharmacists to dispense the compounded prescriptions containing widely used proton pump inhibitors (PPIs). FIRST products will save dispensing time, and can be compounded

The EYLEA (aflibercept) injection was approved by the Food and Drug Administration for the treatment of neovascular (wet) age-related macular degeneration (AMD). Macular degeneration is diagnosed as either

Both the companies have entered into a strategic partnership to deliver a drug candidate. The long-term collaborative project includes three additional specific milestone targets. Hengrui global R&D president

The company will begin marketing and distributing Biocalth products throughout the US and expanding its revenue opportunities in the bone health and joint health market. The combined businesses

CO-1686 is a novel, oral, targeted covalent inhibitor of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC). Clovis, in partnership with Avila Therapeutics, designed